people older idea second trial prove crucial test treatment limits production amyloid likely work best earliest stages disease plaques start building decades symptoms appear time diagnosis given late approach help researchers await results expected 2017 2019 respectively eagerly participants slowed decline cognitive functions reduced amyloid provide strong support hypothesis protein clumps cause alzheimer bace1 inhibitors not game town approach antibody therapies drugs aducanumab dramatically reduced amyloid brains patients mild stages alzheimer small trial reported participants showed slower cognitive decline awaits confirmation larger ongoing clinical trial encouraged aducanumab data selkoe says good shots goal researchers believe antibody therapies work mopping existing